Allurion Technologies (ALURD) Liabilities and Shareholders Equity (2022 - 2026)

Allurion Technologies (ALURD) Liabilities and Shareholders Equity (2022 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Liabilities and Shareholders Equity (Qtr)
1	Abbott Laboratories	186.78 Bn	179.48 Bn	6.27 Bn	110.43 Bn
2	Stryker	131.95 Bn	129.07 Bn	3.81 Bn	46.29 Bn
3	Medtronic	111.27 Bn	102.05 Bn	6.41 Bn	93.03 Bn
4	Boston Scientific	68.58 Bn	67.13 Bn	3.61 Bn	44.35 Bn
5	Edwards Lifesciences	48.31 Bn	44.63 Bn	1.29 Bn	13.32 Bn
6	GE HealthCare Technologies	29.23 Bn	26.94 Bn	1.98 Bn	37.13 Bn
7	Dexcom	28.90 Bn	27.78 Bn	750.30 Mn	6.63 Bn
8	Smith & Nephew	28.19 Bn	27.62 Bn	-	10.46 Bn
9	Koninklijke Philips	24.33 Bn	21.29 Bn	2.01 Bn	31.03 Bn
10	Allurion Technologies	60.75 Mn	55.69 Mn	1.23 Mn	14.00 Mn

Download Data